US · WLYB · PUBLISHING
John Wiley & Sons, Inc. (WLYB) intrinsic value and stock valuation
$51.16as of 2026-11-21 · Mkt cap 2.82B
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
John Wiley & Sons, Inc. DCF and intrinsic value
InvestorsCraft values WLYB with the Chepakovich two-stage DCF model — currently rated fairly valued. How the model works · Run your own DCF prefilled from WLYB’s statements →
John Wiley & Sons, Inc. Graham Number
Graham Number: $39.20d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2012–2026, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $1.68B | $1.68B | $1.87B | $2.02B | $2.08B |
| Operating income | $296.1M | $221.4M | $52.3M | $209M | $219.3M |
| Net income | $221.6M | $84.2M | -$-200.32M | $17.2M | $148.3M |
| EPSd | $4.16M | $1.53M | -$-3.65M | $305.8K | $2.62M |
| Operating cash flow | $260.5M | $202.6M | $207.6M | $277.1M | $339.1M |
| Capital expenditure | -$-83.85M | -$-82.77M | -$-101.76M | -$-106.69M | -$-121.7M |
| Free cash flow | $176.7M | $119.8M | $105.9M | $170.4M | $217.4M |
| Total assets | $2.59B | $2.69B | $2.73B | $3.11B | $3.36B |
| Total debt | $768.9M | $899.2M | $887.3M | $883.5M | $940.1M |
| Net debt | $693.3M | $813.3M | $804M | $776.8M | $839.8M |
| Total equity | $848.2M | $752.2M | $739.7M | $1.05B | $1.14B |
| Cash and short-term investments | $75.6M | $85.9M | $83.3M | $106.7M | $100.4M |
Income statement
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $1.68B | $1.68B | $1.87B | $2.02B | $2.08B |
| Cost of revenue | $484.6M | $431.4M | $579.7M | $692.5M | $700.7M |
| Gross profit | $1.19B | $1.25B | $1.29B | $1.33B | $1.38B |
| Research and development expenses | $0.00 | $0.00 | $0.00 | $32.4M | $35.2M |
| Selling, general and administrative expenses | $0.00 | $947.4M | $1.01B | $1.09B | $1.13B |
| Other expenses | $895.9M | $77.4M | $227.5M | $84.9M | $84.8M |
| Operating expenses | $895.9M | $1.02B | $1.24B | $1.12B | $1.16B |
| Cost and expenses | $1.38B | $1.46B | $1.82B | $1.81B | $1.87B |
| Interest income | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest expense | $43.9M | $52.6M | $49M | $37.7M | $19.8M |
| Depreciation and amortization | $146.3M | $148.2M | $177M | $217.8M | $220.4M |
| Ebitda | $405.2M | $343.6M | $39M | $293.6M | $445.6M |
| Operating income | $296.1M | $221.4M | $52.3M | $209M | $219.3M |
| Total other income/expenses, net | -$-80.98M | -$-78.53M | -$-239.31M | -$-22.79M | -$-9.62M |
| Income before tax | $215.1M | $142.9M | -$-187.05M | $33.1M | $209.7M |
| Income tax expense | -$-6.53M | $58.7M | $13.3M | $15.9M | $61.4M |
| Net income | $221.6M | $84.2M | -$-200.32M | $17.2M | $148.3M |
| Weighted average shares outstanding | $52.5M | $54.1M | $55M | $55.6M | $55.8M |
| Weighted average diluted shares outstanding | $53.3M | $54.8M | $55M | $56.4M | $56.6M |
Balance sheet
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $75.6M | $85.9M | $83.3M | $106.7M | $100.4M |
| Net receivables | $244.2M | $228.4M | $224.2M | $310.1M | $332M |
| Inventory | $19.3M | $22.9M | $26.2M | $30.7M | $36.6M |
| Total current assets | $419.7M | $439.9M | $454M | $541.3M | $550.9M |
| Property, plant and equipment, net | $193.4M | $228.3M | $261.5M | $338.4M | $383.3M |
| Goodwill and intangible assets | $1.71B | $1.72B | $1.71B | $2.06B | $2.23B |
| Long-term investments | $0.00 | $0.00 | $9.69M | -$-144.04M | -$-180.06M |
| Total non-current assets | $2.17B | $2.25B | $2.27B | $2.57B | $2.81B |
| Total assets | $2.59B | $2.69B | $2.73B | $3.11B | $3.36B |
| Accounts payable | $67.2M | $61M | $55.7M | $84.3M | $77.4M |
| Short-term debt | $28.5M | $28.3M | $25.8M | $24.7M | $59.9M |
| Deferred revenue | $451.4M | $462.7M | $483.8M | $504.7M | $538.1M |
| Total current liabilities | $779M | $820.9M | $873.3M | $895.6M | $969.4M |
| Long-term debt | $740.4M | $870.9M | $861.5M | $858.8M | $1.03B |
| Deferred revenue, non-current | $17.2M | $16.7M | $14.8M | $17.4M | $19.1M |
| Total non-current liabilities | $964.6M | $1.12B | $1.11B | $1.17B | $1.25B |
| Capital lease obligations | $85.5M | $99.8M | $112.7M | $135.2M | $153.1M |
| Total liabilities | $1.74B | $1.94B | $1.99B | $2.06B | $2.22B |
| Common stock | $83.2M | $83.2M | $83.2M | $83.2M | $83.2M |
| Retained earnings | $1.74B | $1.59B | $1.58B | $1.86B | $1.92B |
| Accumulated other comprehensive income (loss) | -$-442.22M | -$-478.92M | -$-528.44M | -$-528.9M | -$-508.15M |
| Total equity | $848.2M | $752.2M | $739.7M | $1.05B | $1.14B |
| Total investments | $0.00 | $0.00 | $9.69M | -$-137.64M | -$-179.16M |
| Total debt | $768.9M | $899.2M | $887.3M | $883.5M | $940.1M |
| Net debt | $693.3M | $813.3M | $804M | $776.8M | $839.8M |
Cash flow statement
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Net income | $221.6M | $84.2M | -$-200.32M | $17.2M | $148.3M |
| Depreciation and amortization | $146.3M | $148.2M | $177M | $213.3M | $215.2M |
| Stock-based compensation | $20.6M | $22.2M | $25M | $26.5M | $25.7M |
| Change in working capital | -$-118.2M | -$-132.59M | -$-128.86M | -$-138.63M | -$-104.43M |
| Accounts receivable | -$-19.88M | $7.95M | -$-22.06M | $26.8M | -$-26.32M |
| Inventory | $6.72M | -$-1.42M | $5.44M | -$-520K | $2.31M |
| Accounts payable | -$-12.55M | $8.11M | -$-38.46M | $22.9M | $16.4M |
| Net cash provided by operating activities | $260.5M | $202.6M | $207.6M | $277.1M | $339.1M |
| Investments in property, plant and equipment | -$-51.17M | -$-61.47M | -$-76.08M | -$-106.69M | -$-121.7M |
| Acquisitions, net | $112M | -$-11.24M | -$-4.89M | $8.29M | -$-75.7M |
| Net cash used for investing activities | $28.1M | -$-94.02M | -$-106.64M | -$-98.4M | -$-194.02M |
| Common stock issued | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common stock repurchased | -$-100.08M | -$-60.42M | -$-45.05M | -$-35M | -$-30M |
| Dividends paid | -$-74.36M | -$-76.1M | -$-76.96M | -$-77.3M | -$-77.2M |
| Net cash used for financing activities | -$-298.3M | -$-125.33M | -$-107.22M | -$-168.57M | -$-131.64M |
| Net change in cash | -$-10.31M | -$-13.61M | -$-7.72M | $6.54M | $6.37M |
| Cash at end of period | $75.7M | $85.9M | $99.5M | $107.3M | $100.7M |
| Operating cash flow | $260.5M | $202.6M | $207.6M | $277.1M | $339.1M |
| Capital expenditure | -$-83.85M | -$-82.77M | -$-101.76M | -$-106.69M | -$-121.7M |
| Free cash flow | $176.7M | $119.8M | $105.9M | $170.4M | $217.4M |
Line items
Line items
Line items
About John Wiley & Sons, Inc.
John Wiley & Sons, Inc., a publisher, provides authoritative content, data-driven insights, and knowledge services for the advancement of science, innovation, and learning in the United States, China, the United Kingdom, Japan, Australia, and internationally. The company’s Research segment provides scientific, technical, medical, and scholarly journals, as well as related content and services in the areas of physical sciences and engineering, health sciences, social sciences, and humanities, and life sciences. This segment sells its products direct to research libraries and library consortia, as well as to researchers and professional society members, and other customers; and through independent subscription agents. The company’s Learning segment offers scientific, professional, and education print and digital books; digital courseware to support students and instructors, and assessment services for businesses and professionals. This segment sells its products and services to business and leadership, technology, behavioral health, engineering/architecture, science, and professional education categories through brick-and-mortar and online retailers, wholesalers who supply such bookstores, college bookstores, individual practitioners, corporations, distributor networks, and government agencies. John Wiley & Sons, Inc. was founded in 1807 and is headquartered in Hoboken, New Jersey.
- CEO
- Matthew S. Kissner
- Employees
- 4.5K
- Beta
- 0.75
Explore
Frequently asked questions
What is the intrinsic value of John Wiley & Sons, Inc. (WLYB)?
John Wiley & Sons, Inc. (WLYB) is currently fairly valued based on the InvestorsCraft IC model — IC value is within 20% of the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is WLYB undervalued?
WLYB trades at a price of $51.16 (Nov 21, 2026): fairly valued — IC value is within 20% of the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.